Christina Berry, NP
Nurse Practitioner · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Christina Berry’s office at (415) 600-1020 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$35,850
Medicare paid this office $35,850 for 121 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 111 | $27,521 | $98 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 70 | $3,859 | $25 |
| Long return visit (40+ min) | 17 | $2,129 | $118 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 64 | $1,343 | $13 |
Who their Medicare patients are
121 Original Medicare patients in 2024. Average age 75 · Women 45% · Health risk score 1.34. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 75% · Chronic kidney disease 63% · Coronary heart disease 34% · Atrial fibrillation 20% · Depression 20% · Heart failure 18%.
The office billed $154,157, Medicare allowed $48,448 and paid $35,850; for 576 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 121 | 576 | 75 | 1.34 | $154,157 | $35,850 |
| 2023 | 120 | 697 | 75 | 1.71 | $161,241 | $40,703 |
| 2022 | 139 | 595 | 76 | 1.52 | $139,303 | $39,392 |
| 2021 | 145 | 674 | 76 | 1.52 | $121,753 | $38,319 |
| 2020 | 98 | 439 | 76 | 1.71 | $98,392 | $30,210 |
| 2019 | 121 | 809 | 75 | 1.44 | $126,138 | $33,747 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 108 | $29,981 | $95 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 59 | $3,408 | $26 |
| Long return visit (40+ min) | 16 | $3,261 | $136 |
2022: 3 services
| Return visit (30+ min) | 121 | $27,297 | $99 |
| Long return visit (40+ min) | 46 | $9,024 | $141 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 22 | $821 | $27 |
2021: 4 services
| Return visit (30+ min) | 108 | $23,444 | $101 |
| Long return visit (40+ min) | 40 | $6,424 | $146 |
| Telephone medical discussion with physician, 21-30 minutes | 16 | $2,099 | $105 |
| Blood glucose (sugar) test performed by hand-held instrument | 11 | $39 | $3 |
2020: 5 services
| Return visit (30+ min) | 82 | $17,362 | $83 |
| Telephone medical discussion with physician, 21-30 minutes | 37 | $6,857 | $89 |
| Long return visit (40+ min) | 18 | $2,195 | $116 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 19 | $644 | $27 |
| Blood glucose (sugar) test performed by hand-held instrument | 14 | $55 | $3 |
2019: 3 services
| Return visit (30+ min) | 111 | $23,296 | $86 |
| Short return visit (20+ min) | 11 | $659 | $60 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 14 | $436 | $27 |
Drugs they prescribed that Part D paid
$861,685
Pharmacies billed $861,685 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,148) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
283 generic and 798 brand-name prescriptions · $861,685 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 184 | $246,521 | $1,340 |
| Mounjaro | 164 | $202,548 | $1,235 |
| Trulicity | 112 | $133,607 | $1,193 |
| Jardiance | 102 | $96,164 | $943 |
| Tresiba Flextouch U-100 | 56 | $34,709 | $620 |
See all 21 drugs
| Ozempic | 184 | $246,521 | $1,340 |
| Mounjaro | 164 | $202,548 | $1,235 |
| Trulicity | 112 | $133,607 | $1,193 |
| Jardiance | 102 | $96,164 | $943 |
| Tresiba Flextouch U-100 | 56 | $34,709 | $620 |
| Farxiga | 29 | $30,050 | $1,036 |
| Testosterone | 26 | $12,540 | $482 |
| Januvia | 12 | $12,314 | $1,026 |
| Toujeo Solostar | 22 | $11,206 | $509 |
| Vascepa | 15 | $8,528 | $569 |
| Tradjenta | 17 | $8,090 | $476 |
| Nano 2nd Gen Pen Needle | 40 | $4,427 | $111 |
| Novolog Flexpen | 15 | $4,109 | $274 |
| Metformin Hcl Er | 66 | $1,093 | $17 |
| Glipizide Er | 20 | $515 | $26 |
| Glimepiride | 21 | $362 | $17 |
| Metformin | 30 | $317 | $11 |
| Atorvastatin | 37 | $231 | $6 |
| Repaglinide | 12 | $174 | $14 |
| Glipizide | 20 | $129 | $6 |
| Rosuvastatin | 15 | $26 | $2 |
Year by year
| 2024 | 1,148 | 168 | 0% (0) | 70% | $861,685 |
| 2023 | 1,106 | 164 | 0% (0) | 67% | $938,875 |
| 2022 | 1,173 | 178 | 0% (0) | 66% | $897,642 |
| 2021 | 957 | 162 | 0% (0) | 65% | $595,100 |
| 2020 | 735 | 135 | 0% (0) | 60% | $423,762 |
| 2019 | 862 | 214 | None | 50% | $356,067 |
| 2018 | 1,120 | 169 | 0% (0) | 38% | $334,717 |
| 2017 | 362 | 100 | 0% (0) | None | $108,713 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 21 drugs
| Ozempic | 155 | $270,453 | $1,745 |
| Trulicity | 199 | $258,025 | $1,297 |
| Mounjaro | 91 | $115,024 | $1,264 |
| Jardiance | 79 | $94,057 | $1,191 |
| Tresiba Flextouch U-100 | 64 | $38,300 | $598 |
| Farxiga | 19 | $17,539 | $923 |
| Novolog Flexpen | 21 | $16,699 | $795 |
| Humalog Kwikpen U-100 | 14 | $14,751 | $1,054 |
| Januvia | 13 | $9,915 | $763 |
| Lantus Solostar | 13 | $8,296 | $638 |
| Icosapent Ethyl | 13 | $4,670 | $359 |
| Nano 2nd Gen Pen Needle | 28 | $2,955 | $106 |
| Metformin Hcl Er | 67 | $1,617 | $24 |
| Ultra-Fine Nano Pen Needle | 12 | $1,510 | $126 |
| Repaglinide | 16 | $1,284 | $80 |
| Atorvastatin | 39 | $1,016 | $26 |
| Glipizide Er | 27 | $929 | $34 |
| Rosuvastatin | 19 | $530 | $28 |
| Metformin | 26 | $455 | $18 |
| Glipizide | 26 | $311 | $12 |
| Glimepiride | 12 | $178 | $15 |
2022: 24 drugs
| Trulicity | 300 | $376,372 | $1,255 |
| Ozempic | 119 | $189,016 | $1,588 |
| Jardiance | 63 | $69,446 | $1,102 |
| Tresiba Flextouch U-100 | 60 | $37,196 | $620 |
| Tresiba Flextouch U-200 | 15 | $24,435 | $1,629 |
| Novolog Flexpen | 17 | $19,801 | $1,165 |
| Synjardy Xr | 17 | $17,203 | $1,012 |
| Mounjaro | 15 | $15,100 | $1,007 |
| Farxiga | 14 | $12,972 | $927 |
| Januvia | 16 | $11,469 | $717 |
| Toujeo Solostar | 13 | $9,449 | $727 |
| Lantus Solostar | 17 | $9,122 | $537 |
| Humalog Kwikpen U-100 | 12 | $8,658 | $721 |
| Vascepa | 15 | $6,923 | $462 |
| Tradjenta | 12 | $6,392 | $533 |
| Testosterone | 15 | $5,842 | $389 |
| Nano 2nd Gen Pen Needle | 20 | $2,064 | $103 |
| Glipizide Er | 60 | $1,860 | $31 |
| Metformin Hcl Er | 64 | $1,582 | $25 |
| Metformin | 27 | $1,289 | $48 |
| Repaglinide | 17 | $1,197 | $70 |
| Atorvastatin | 34 | $728 | $21 |
| Rosuvastatin | 21 | $498 | $24 |
| Glipizide | 33 | $151 | $5 |
2021: 25 drugs
| Trulicity | 177 | $186,269 | $1,052 |
| Ozempic | 66 | $90,576 | $1,372 |
| Tresiba Flextouch U-100 | 85 | $47,770 | $562 |
| Tresiba Flextouch U-200 | 23 | $34,839 | $1,515 |
| Humalog | 24 | $26,373 | $1,099 |
| Jardiance | 23 | $23,016 | $1,001 |
| Novolog Flexpen | 17 | $18,043 | $1,061 |
| Humalog Kwikpen U-100 | 25 | $17,593 | $704 |
| Vascepa | 21 | $14,561 | $693 |
| Tresiba | 18 | $12,981 | $721 |
| Tradjenta | 21 | $12,894 | $614 |
| Toujeo Solostar | 18 | $11,305 | $628 |
| Januvia | 13 | $10,299 | $792 |
| Fiasp Flextouch | 12 | $8,646 | $721 |
| Nano 2nd Gen Pen Needle | 27 | $2,288 | $85 |
| Metformin Hcl Er | 57 | $1,658 | $29 |
| Comfort Ez Pen Needle | 13 | $1,505 | $116 |
| Glipizide Er | 37 | $1,387 | $37 |
| Repaglinide | 11 | $1,140 | $104 |
| Atorvastatin | 23 | $429 | $19 |
| Rosuvastatin | 17 | $327 | $19 |
| Glipizide | 39 | $223 | $6 |
| Metformin | 16 | $119 | $7 |
| Amlodipine Besylate | 14 | $56 | $4 |
| Alcohol Swabs | 12 | $29 | $2 |
2020: 21 drugs
| Trulicity | 91 | $110,645 | $1,216 |
| Tresiba Flextouch U-100 | 72 | $44,017 | $611 |
| Ozempic | 38 | $39,012 | $1,027 |
| Tresiba Flextouch U-200 | 23 | $31,480 | $1,369 |
| Novolog Flexpen | 22 | $18,087 | $822 |
| Jardiance | 14 | $17,905 | $1,279 |
| Victoza 3-Pak | 13 | $16,092 | $1,238 |
| Humalog Kwikpen U-100 | 14 | $13,320 | $951 |
| Vascepa | 13 | $7,714 | $593 |
| Tradjenta | 14 | $6,417 | $458 |
| Januvia | 11 | $6,364 | $579 |
| Tresiba | 13 | $5,446 | $419 |
| Ultra-Fine Nano Pen Needle | 15 | $1,292 | $86 |
| Glipizide Er | 39 | $918 | $24 |
| Metformin Hcl Er | 42 | $774 | $18 |
| Rosuvastatin | 15 | $475 | $32 |
| Atorvastatin | 15 | $259 | $17 |
| Glipizide | 23 | $132 | $6 |
| Lisinopril | 11 | $123 | $11 |
| Metformin | 14 | $107 | $8 |
| Glimepiride | 11 | $67 | $6 |
2019: 28 drugs
| Trulicity | 82 | $84,060 | $1,025 |
| Victoza 3-Pak | 29 | $30,343 | $1,046 |
| Tresiba Flextouch U-100 | 41 | $22,934 | $559 |
| Nutropin Aq Nuspin | 16 | $21,788 | $1,362 |
| Jardiance | 22 | $19,345 | $879 |
| Bydureon Bcise | 16 | $18,009 | $1,126 |
| Humalog Kwikpen U-100 | 19 | $17,366 | $914 |
| Ozempic | 22 | $16,552 | $752 |
| Novolog Flexpen | 14 | $12,717 | $908 |
| Tresiba Flextouch U-200 | 12 | $11,777 | $981 |
| Januvia | 13 | $9,966 | $767 |
| Lantus Solostar | 13 | $5,328 | $410 |
| Lantus | 13 | $4,108 | $316 |
| Vascepa | 12 | $3,701 | $308 |
| Nateglinide | 16 | $2,497 | $156 |
| Repaglinide | 19 | $1,878 | $99 |
| Rosuvastatin | 24 | $1,642 | $68 |
| Ultra-Fine Nano Pen Needle | 20 | $1,595 | $80 |
| Synthroid | 11 | $1,367 | $124 |
| Metformin Hcl Er | 58 | $1,050 | $18 |
| Atorvastatin | 40 | $668 | $17 |
| Levoxyl | 22 | $486 | $22 |
| Glimepiride | 29 | $481 | $17 |
| Desmopressin Acetate | 11 | $323 | $29 |
| Lisinopril | 20 | $276 | $14 |
| Metformin | 11 | $210 | $19 |
| Carvedilol | 17 | $196 | $12 |
| Losartan | 16 | $126 | $8 |
2018: 30 drugs
| Trulicity | 78 | $72,261 | $926 |
| Bydureon Bcise | 52 | $44,491 | $856 |
| Victoza 3-Pak | 15 | $21,982 | $1,465 |
| Jardiance | 24 | $18,065 | $753 |
| Humalog Kwikpen U-100 | 12 | $10,904 | $909 |
| Toujeo Solostar | 16 | $8,851 | $553 |
| Lantus | 12 | $4,114 | $343 |
| Repaglinide | 57 | $3,422 | $60 |
| Rosuvastatin | 39 | $2,751 | $71 |
| Nateglinide | 20 | $1,944 | $97 |
| Atorvastatin | 62 | $1,385 | $22 |
| Glimepiride | 61 | $1,306 | $21 |
| Synthroid | 15 | $1,215 | $81 |
| Ezetimibe | 11 | $1,096 | $100 |
| Ultra-Fine Nano Pen Needle | 17 | $1,082 | $64 |
| Levoxyl | 44 | $983 | $22 |
| Bupropion Xl | 15 | $539 | $36 |
| Metformin | 28 | $524 | $19 |
| Pioglitazone | 21 | $470 | $22 |
| Metformin Hcl Er | 38 | $434 | $11 |
| Acarbose | 12 | $430 | $36 |
| Irbesartan | 20 | $428 | $21 |
| Losartan-Hydrochlorothiazide | 14 | $249 | $18 |
| Gabapentin | 11 | $222 | $20 |
| Lisinopril | 20 | $176 | $9 |
| Carvedilol | 18 | $172 | $10 |
| Amlodipine Besylate | 18 | $160 | $9 |
| Fluoxetine | 15 | $145 | $10 |
| Hydrochlorothiazide | 26 | $127 | $5 |
| Allopurinol | 11 | $73 | $7 |
2017: 10 drugs
| Trulicity | 39 | $31,486 | $807 |
| Jardiance | 14 | $9,988 | $713 |
| Rosuvastatin | 14 | $1,137 | $81 |
| Synthroid | 16 | $798 | $50 |
| Bupropion Xl | 13 | $373 | $29 |
| Atorvastatin | 20 | $354 | $18 |
| Glimepiride | 16 | $288 | $18 |
| Levoxyl | 11 | $284 | $26 |
| Pioglitazone | 15 | $232 | $15 |
| Metformin | 15 | $217 | $14 |
Money from drug and device companies
$278 in 2025
| 2025 | 1 | 4 | None | $278 |
| 2024 | 2 | 2 | None | $306 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Stryker | Flowtriever | $278 | 4 payments
|
See all 4 published payments
| Stryker | Meals · 2025-09-05 | Flowtriever | $42 |
| Stryker | Meals · 2025-08-20 | Flowtriever | $16 |
| Stryker | Meals · 2025-08-07 | Clottriever Bold Catheter | $50 |
| Stryker | Meals · 2025-06-03 | Flowtriever | $170 |
See earlier years (2024)
2024: $306
| Medtronic | Minimed 780g | $170 | 1 payment
|
| Tandem Diabetes Care | T:Slim X2 Insulin Pump With Control-Iq | $136 | 1 payment
|
Professional record
- NPI
- 1073060943
- Licence
- CA 95005904, CT 006698
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2016-09-08
- NPI last updated
- 2020-02-18
- NPI record certified
- 2020-02-18
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 10455 S De Anza Blvd, Cupertino, CA, 95014